These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9033028)

  • 1. Cholesterol requirement and metabolism in Entamoeba histolytica.
    Lujan HD; Diamond LS
    Arch Med Res; 1997; 28 Spec No():96-7. PubMed ID: 9033028
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiochemical alteration of surface membrane of axenic Entamoeba histolytica during repeated cholesterol passage.
    Gaur AK; Bajpai VK; Rastogi AK; Shipstone AC; Garg NK
    Indian J Biochem Biophys; 1987 Feb; 24(1):34-8. PubMed ID: 2887508
    [No Abstract]   [Full Text] [Related]  

  • 3. Auxotrophy to lipoproteins of Entamoeba histolytica cultivated under axenic conditions.
    Mata-Cárdenas BD; Vargas-Villarreal J; Martínez-Rodríguez HG; Castro-Garza J; González-Garza MT; Said-Fernández S
    Parasitol Res; 2000 Dec; 86(12):1018-21. PubMed ID: 11133106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entamoeba histolytica: isoprenylation of p21ras and p21rap in vitro.
    Shen PS; Sanford JC; Samuelson J
    Exp Parasitol; 1996 Jan; 82(1):65-8. PubMed ID: 8617332
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxygen free radicals produced by Entamoeba histolytica are able to cause biological damage.
    Muñoz-Sánchez JL; Jiménez-Cardoso E; Cervantes-Cervantes P; Crisóstomo Vázquez MP
    Arch Med Res; 1997; 28 Spec No():154-5. PubMed ID: 9033051
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of the monocyte locomotion inhibitory factor (MLIF) by axenically grown Entamoeba histolytica: synthesis or degradation?
    Rico G; Ximénez C; Ramos F; Kretschmer RR
    Arch Med Res; 1997; 28 Spec No():235-6. PubMed ID: 9033084
    [No Abstract]   [Full Text] [Related]  

  • 7. The monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica fails to affect the locomotion and the respiratory burst of human eosinophils in vitro.
    Rico G; Kretschmer RR
    Arch Med Res; 1997; 28 Spec No():233-4. PubMed ID: 9033083
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of contact cutaneous delayed hypersensitivity reactions to DNBC in guinea pigs by the monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica.
    Giménez Scherer JA; Rico G; Fernández-Diez J; Kretschmer RR
    Arch Med Res; 1997; 28 Spec No():237-8. PubMed ID: 9033085
    [No Abstract]   [Full Text] [Related]  

  • 9. Zymodeme stability of Entamoeba histolytica and E. dispar.
    Jackson TF; Suparsad S
    Arch Med Res; 1997; 28 Spec No():304-5. PubMed ID: 9033111
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific proteins and culture media proteins found in trophozoites of E. histolytica obtained by axenic cultivation].
    García-Tamayo F; Hashimoto-Yañez B; Kumate J
    Arch Invest Med (Mex); 1980; 11(1 Suppl):159-62. PubMed ID: 6258511
    [No Abstract]   [Full Text] [Related]  

  • 11. Entamoeba histolytica is unable to use free cholesterol, phospholipids, and fatty acids under axenic cultivation conditions.
    Mata-Cárdenas BD; Vargas-Villarreal J; González-Salazar F; Martínez-Rodríguez H; Morales-Vallarta M; Said-Fernández S
    Arch Med Res; 2000; 31(4 Suppl):S212-3. PubMed ID: 11070288
    [No Abstract]   [Full Text] [Related]  

  • 12. Entamoeba histolytica: observations on metabolism based on the genome sequence.
    Anderson IJ; Loftus BJ
    Exp Parasitol; 2005 Jul; 110(3):173-7. PubMed ID: 15955308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term subcultivation in axenic conditions of Entamoeba histolytica in a serum-free media.
    Mata-Cárdenas BD; Morales-Vallarta M; Vargas-Villarreal J; Said-Fernández S
    Arch Med Res; 1997; 28 Spec No():106-7. PubMed ID: 9033031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histochemical studies of lipid metabolism in Entamoeba histolytica (Schaudinn, 1903)].
    Kuźna W
    Wiad Parazytol; 1987; 33(6):657-61. PubMed ID: 2900579
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemoglobinases in Entamoeba histolytica HM-1: IMSS.
    Serrano J; Negrete E; Reyes M; de la Garza M
    Arch Med Res; 1997; 28 Spec No():202-3. PubMed ID: 9033072
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between free radicals produced by entamoeba histolytica and its proteases complex activity.
    Crisóstomo-Vázquez MP; Cervantes-Cervantes MP; Jiménez-Cardoso E; Muñoz-Sánchez JL
    Rev Latinoam Microbiol; 2002; 44(2):79-82. PubMed ID: 17063776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entamoeba histolytica: axenization and characterization of isolated samples from symptomatic and asymptomatic patients from different regions of Brazil.
    Silva EF; Gómes MA; Barral de Martínez AM
    Arch Med Res; 1997; 28 Spec No():288-9. PubMed ID: 9033104
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein biosynthesis by Entamoeba histolytica in culture.
    Mendoza F; Arcos L; Ortíz-Ortíz L; Diaz de León L
    Arch Invest Med (Mex); 1982; 13 Suppl 3():71-6. PubMed ID: 6295331
    [No Abstract]   [Full Text] [Related]  

  • 19. Membrane acid phosphatase (MAP) from Entamoeba histolytica.
    Anaya-Ruíz M; Rosales-Encina JL; Talamás-Rohana P
    Arch Med Res; 1997; 28 Spec No():182-3. PubMed ID: 9033063
    [No Abstract]   [Full Text] [Related]  

  • 20. The tail domain of Entamoeba histolytica myosin IB bind F-actin.
    Vargas MA; Voigt H; Sansonetti P; Guillén N
    Arch Med Res; 1997; 28 Spec No():137-8. PubMed ID: 9033044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.